CTO & Medical director Stephane Roche Researcher, Stéphane ROCHE holds a PhD in Biological and Medical Engineering and is a former University Hospital Assistant of the Grenoble Hospitals. Stéphane ROCHE also holds a Habilitation to Supervise Research. He has worked … Read More
English
Ludovic de ROCHEFORT, PhD, HDR
Founder and CEO Ludovic de Rochefort has a PhD in medical imaging and holds an habilitation to conduct research. He is a certified LSTI ISO/IEC 27001 Implementer (information security management), and Data Protection Officer (CNIL/PECB DPO competencies, sensitive data processing), … Read More
QSM as an imaging biomarker for Alzheimer’s disease
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai, Kenichi Oishi and Noriyuki Matsukawa Frontiers In Neuroscience, 5 august 2022 Alzheimer’s disease (AD) is the most common type of … Read More
QSM as an imaging biomarker for Alzheimer’s disease
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai, Kenichi Oishi and Noriyuki Matsukawa Frontiers In Neuroscience, 5 august 2022 Alzheimer’s disease (AD) is the most common type of … Read More
Ventio – innovation in digital health
Indeed, the company has been hosted by Marseille Innovation for one year and has benefited from the support of the Regional Institute of Business Leaders (IRCE), and thus from the advice of these networks of experts on the critical issues … Read More
Pseudonymization and anonymization: what rules apply to our health data?
Pseudonymization and anonymization: what rules apply to our health data? 2142 zettabytes. This is the estimated global volume of digital data by 2035. A figure that makes you dizzy, especially if you compare it to the volumes of 2010 and … Read More